Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heike Wulff

Showing results (11-20 of 222) with videos related to

Pageof 23
Sort By:
Nature Chemical Biology|July 23, 2013
Channels: Sticking to nooks and cranniesHeike Wulff, Vladimir Yarov-Yarovoy
Expert Review of Clinical Pharmacology|November 25, 2011
Therapeutic potential of KCa3.1 blockers: recent advances and promising trendsHeike Wulff, Neil A Castle
Annual Review of Immunology|April 12, 2015
Ion channels in innate and adaptive immunityStefan Feske, Heike Wulff, Edward Y Skolnik
Archives of Toxicology|October 18, 2017
GABA<sub>A</sub> receptor subtype selectivity of the proconvulsant rodenticide TETSBrandon Pressly, Hai M Nguyen, Heike Wulff
Channels (Austin, Tex.)|September 7, 2017
Are there superagonists for calcium-activated potassium channels?Brandon M Brown, Heesung Shim, Heike Wulff
Current Research in Physiology|December 18, 2023
Ca<sup>2+</sup>-regulated expression of high affinity methylaminoisobutryic acid transport in hippocampal neurons inhibited by riluzole and novel neuroprotective aminothiazolesJeffrey D Erickson, Thomas Kyllo, Heike Wulff
Current Opinion in Drug Discovery & Development|October 29, 2003
Potassium channels as therapeutic targets for autoimmune disordersHeike Wulff, Christine Beeton, K George Chandy
Expert Opinion on Therapeutic Targets|January 9, 2010
Vascular KCa-channels as therapeutic targets in hypertension and restenosis diseaseRalf Köhler, Brajesh P Kaistha, Heike Wulff
Current Neuropharmacology|July 6, 2017
KCa3.1 Channel Modulators as Potential Therapeutic Compounds for GlioblastomaBrandon M Brown, Brandon Pressley, Heike Wulff
Current Medicinal Chemistry|December 8, 2004
Potassium channel blockade by the sea anemone toxin ShK for the treatment of multiple sclerosis and other autoimmune diseasesRaymond S Norton, Michael W Pennington, Heike Wulff
Pageof 23

Showing results (11-20 of 222) with videos related to

Sort By:
Pageof 23
Nature Chemical Biology|July 23, 2013
Channels: Sticking to nooks and cranniesHeike Wulff, Vladimir Yarov-Yarovoy
Expert Review of Clinical Pharmacology|November 25, 2011
Therapeutic potential of KCa3.1 blockers: recent advances and promising trendsHeike Wulff, Neil A Castle
Annual Review of Immunology|April 12, 2015
Ion channels in innate and adaptive immunityStefan Feske, Heike Wulff, Edward Y Skolnik
Archives of Toxicology|October 18, 2017
GABA<sub>A</sub> receptor subtype selectivity of the proconvulsant rodenticide TETSBrandon Pressly, Hai M Nguyen, Heike Wulff
Channels (Austin, Tex.)|September 7, 2017
Are there superagonists for calcium-activated potassium channels?Brandon M Brown, Heesung Shim, Heike Wulff
Current Research in Physiology|December 18, 2023
Ca<sup>2+</sup>-regulated expression of high affinity methylaminoisobutryic acid transport in hippocampal neurons inhibited by riluzole and novel neuroprotective aminothiazolesJeffrey D Erickson, Thomas Kyllo, Heike Wulff
Current Opinion in Drug Discovery & Development|October 29, 2003
Potassium channels as therapeutic targets for autoimmune disordersHeike Wulff, Christine Beeton, K George Chandy
Expert Opinion on Therapeutic Targets|January 9, 2010
Vascular KCa-channels as therapeutic targets in hypertension and restenosis diseaseRalf Köhler, Brajesh P Kaistha, Heike Wulff
Current Neuropharmacology|July 6, 2017
KCa3.1 Channel Modulators as Potential Therapeutic Compounds for GlioblastomaBrandon M Brown, Brandon Pressley, Heike Wulff
Current Medicinal Chemistry|December 8, 2004
Potassium channel blockade by the sea anemone toxin ShK for the treatment of multiple sclerosis and other autoimmune diseasesRaymond S Norton, Michael W Pennington, Heike Wulff
Pageof 23